ArticleBrain topography2022
Selecting Multiple Node Statistics Jointly from Functional Connectivity Networks for Brain Disorders Identification.
Article in Brain topography, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 6 citations in OpenAlex.
- Identification of Major Depressive Disorder Using Multiple Functional Connection Patterns.CNS neuroscience & therapeutics · 2026Article
- Random Walk-Based Node Feature Learning for Major Depressive Disorder Identification Through Multi-Site rs-fMRI Data.Human brain mapping · 2025Article
- Article
- The effect of node features on GCN-based brain network classification: an empirical study.PeerJ · 2023Article
- Multi-band network fusion for Alzheimer's disease identification with functional MRI.Frontiers in psychiatry · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 2 countries.
Funding
Abstract
Functional connectivity networks (FCN) analysis is instructive for the diagnosis of brain diseases, such as mild cognitive impairment (MCI) and major depressive disorder (MDD) at their early stages. As the critical step of FCN analysis, feature representation provides the basis for finding potential biomarkers of brain diseases. In previous studies, different node statistics (e.g. local efficiency and local clustering coefficients) are usually extracted from FCNs as features for the diagnosis/classification task, which can specifically locate disease-related regions on the node level, so as to help us understand the neurodevelopmental roots of brain disorders. However, each node statistic is proposed only considering a kind of specific network property, which has one-sidedness and limitations. As a result, it is incomplete to represent a node with only one statistic. To resolve this issue, we put forward a novel scheme to select multiple node statistics jointly from the estimated FCNs for automated classification, called multiple node statistics feature selection (MNSFS). Specifically, we first extract multiple statistics from the same nodes and assign each kind of statistic into a group. Then, sparse group least absolute shrinkage and selection operator (sgLASSO) is used to select groups (nodes) and statistics in the groups towards a better classification performance. Such a technique enables us to simultaneously locate the discriminative brain regions, as well as the specific statistics associated with these brain regions, making the classification results more interpretable. We conducted our scheme on two public databases for identifying subjects with MCI and MDD from normal controls. Experimental results show that the proposed scheme achieves superior classification accuracy and features interpreted on the benchmark datasets.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.